These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6947236)

  • 21. An oligosaccharide biosynthetic defect in concanavalin A-resistant Chinese hamster ovary (CHO) cells that enhances NK reactivity in vitro and in vivo.
    Pohajdak B; Wright JA; Greenberg AJ
    J Immunol; 1984 Nov; 133(5):2423-9. PubMed ID: 6481160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
    Johnson PW; Trimble WS; Hozumi N; Roder JC
    J Immunol; 1987 Jun; 138(11):3996-4003. PubMed ID: 3495578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon and butyrate treatment leads to a decreased sensitivity of NK target cells to lysis by homologous but not by heterologous effector cells.
    Laskay T; Kiessling R
    Nat Immun Cell Growth Regul; 1986; 5(4):211-20. PubMed ID: 3095635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid).
    Dorshkind K; Pollack SB; Bosma MJ; Phillips RA
    J Immunol; 1985 Jun; 134(6):3798-801. PubMed ID: 3989296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium.
    Ryan JC; Niemi EC; Goldfien RD; Hiserodt JC; Seaman WE
    J Immunol; 1991 Nov; 147(9):3244-50. PubMed ID: 1919012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence, and cytolysis.
    Helfand SL; Werkmeister J; Roder JC
    J Exp Med; 1982 Aug; 156(2):492-505. PubMed ID: 6178787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain.
    Yamasaki T; Moritake K; Klein G
    J Neurosurg; 2003 Mar; 98(3):599-606. PubMed ID: 12650434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a murine lymphoma model system for the characterization of natural killer:tumor cell interactions.
    Smithson G; Wolcott RM; Chervenak R
    Cancer Res; 1992 Aug; 52(15):4149-56. PubMed ID: 1638530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced humoral and cellular cytotoxic sensitivity in histocompatibility variants of the YAC (Moloney) lymphoma.
    Dalianis T; Ahrlund-Richter L; Merino F; Klein E; Klein G
    Immunogenetics; 1981; 12(3-4):371-80. PubMed ID: 7203561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants.
    Ljunggren HG; Sturmhöfel K; Wolpert E; Hämmerling GJ; Kärre K
    J Immunol; 1990 Jul; 145(1):380-6. PubMed ID: 2113557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
    Laybourn KA; Hiserodt JC; Abruzzo LV; Varani J
    Cancer Res; 1986 Jul; 46(7):3407-12. PubMed ID: 2939945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis and enrichment of murine natural killer cells with the fluorescence-activated cell sorter.
    Tam MR; Emmons SL; Pollack SB
    J Immunol; 1980 Feb; 124(2):650-5. PubMed ID: 6985934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between murine natural antibodies and natural killer cells: recognition of separate target structures as revealed by differential in vitro expression and dependence on glycosylation.
    Grönberg A; Eriksson E; Sinangil F; Rönnholm M; Feizi T; Minden P; Kiessling R
    J Natl Cancer Inst; 1985 Jan; 74(1):67-75. PubMed ID: 2982055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.
    Piontek GE; Taniguchi K; Ljunggren HG; Grönberg A; Kiessling R; Klein G; Kärre K
    J Immunol; 1985 Dec; 135(6):4281-8. PubMed ID: 3905967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the cytolytic activity of a cloned antigen-specific T suppressor cell derived from a tolerant CBA/J mouse.
    Heuer J; Opalka B; Rassat J; Themann H; Kölsch E
    Eur J Immunol; 1983 Jul; 13(7):551-5. PubMed ID: 6223825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of altered membrane structure on NK cell-mediated cytotoxicity. II. Conversion of NK-resistant tumor cells into NK-sensitive targets upon fusion with liposomes containing NK-sensitive membranes.
    Roozemond RC; van der Geer P; Bonavida B
    J Immunol; 1986 May; 136(10):3921-9. PubMed ID: 3701064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line.
    Howell DN; Andreotti PE; Dawson JR; Cresswell P
    J Immunol; 1985 Feb; 134(2):971-6. PubMed ID: 3871222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.